“Dupilumab Improves Patient-Reported Outcomes as Early as 1 Month among Adults with Prurigo Nodularis in Clinical Practice: Initial Results from the RELIEVE-PN Study” (2024) SKIN The Journal of Cutaneous Medicine, 8(6), p. s506. doi:10.25251/skin.8.supp.506.